TREATMENT VARIATION AND ITS IMPLICATION FOR SEVERE FONTAN-ASSOCIATED PROTEIN LOSING ENTEROPATHY

Methods This 12-center, retrospective cohort study of all post-Fontan patients (pts) with PLE referred for heart transplant (HTx) evaluation from 2003-2015 collected data including demographics, medical history, PLE-specific data including disease and treatment details, and outcomes including pre-an...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American College of Cardiology 2018-03, Vol.71 (11), p.A624-A624
Main Authors: Johnson, Jonathan N., Yu, Sunkyung, Lowery, Ray, Butts, Ryan, Castleberry, Chesney, Chen, Sharon, Edens, Erik, Godown, Justin, Gossett, Jeffrey, Kemna, Mariska, Lin, Kimberly, Simpson, Kathleen, West, Shawn, Wilmot, Ivan, Schumacher, Kurt
Format: Article
Language:English
Subjects:
Cardiology
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Methods This 12-center, retrospective cohort study of all post-Fontan patients (pts) with PLE referred for heart transplant (HTx) evaluation from 2003-2015 collected data including demographics, medical history, PLE-specific data including disease and treatment details, and outcomes including pre-and post-HTx survival. The lack of uniform treatment and potential impact of unique therapies on survival suggests that formal guidelines to PLE treatment are necessary.
ISSN:0735-1097
1558-3597
DOI:10.1016/S0735-1097(18)31165-3